TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $58,039,000 | +1689.7% | 771,289 | +538.6% | 0.04% | +1750.0% |
| Q1 2022 | $3,243,000 | +52.3% | 120,777 | +170.5% | 0.00% | +100.0% |
| Q4 2021 | $2,130,000 | +187.1% | 44,647 | +299.8% | 0.00% | – |
| Q3 2021 | $742,000 | -51.4% | 11,168 | -42.9% | 0.00% | – |
| Q2 2021 | $1,526,000 | -77.0% | 19,563 | -72.2% | 0.00% | -100.0% |
| Q1 2021 | $6,648,000 | +275.2% | 70,282 | +383.3% | 0.00% | +300.0% |
| Q4 2020 | $1,772,000 | +6.7% | 14,542 | -23.5% | 0.00% | -50.0% |
| Q3 2020 | $1,660,000 | -75.0% | 19,000 | -81.5% | 0.00% | -77.8% |
| Q2 2020 | $6,630,000 | +27.3% | 102,647 | +22.8% | 0.01% | +28.6% |
| Q4 2019 | $5,207,000 | -50.0% | 83,589 | -69.9% | 0.01% | -56.2% |
| Q3 2019 | $10,424,000 | – | 277,247 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |